CRA ECP RSS FeedNews from CRA European Competition Practicehttp://www.crai.com/ecp/news/rss.xmlCopyright 2008 CRAIXML Infinity - see www.xmlinfinity.com for more detailsOFT clears Ambassador/Live Nation theatre deal/news/news_2010/Ambassador.htm/news/news_2010/Ambassador.htmAutorité de la concurrence rejects complaint against Carrefour/news/news_2010/Carrefour.htm/news/news_2010/Carrefour.htmSouth African Competition Tribunal finds that SAA abused its dominance in complaint brought by Comair/news/news_2010/SAA-Comair.htm/news/news_2010/SAA-Comair.htmFrench Competition Authority clears acquisition of TMC and NT1 by TF1/news/news_2010/TMC_TF1.htm/news/news_2010/TMC_TF1.htmThe French Appeal Court slashes fines in the steel wholesaling cartel/news/news_2010/Steel_Wholesaling.htm/news/news_2010/Steel_Wholesaling.htmFrench Competition Authority appoints CRA`s Academic Associate Thibaud Vergé as Chief Economist/news/news_2010/Thibaud_Verge.htm/news/news_2010/Thibaud_Verge.htmEuropean Commission approves restructuring plan of Lloyds Banking Group/news/news_2009/Lloyds_Restructure.htm/news/news_2009/Lloyds_Restructure.htm7th Annual Competition Conference in Brussels/news/news_2009/BruxConf09.htm/news/news_2009/BruxConf09.htmAutorité de la Concurrence rejects interim measures against Janssen-Cilag/news/news_2009/Janssen-Cilag.htm/news/news_2009/Janssen-Cilag.htmPanasonic and Sanyo merger cleared at Phase I/news/news_2009/panasonic-sanyo-merger.htm/news/news_2009/panasonic-sanyo-merger.htmRyanair appeal heard before the CFI/news/news_2009/Ryanair_Appeal.htm/news/news_2009/Ryanair_Appeal.htmProfessor John Van Reenen awarded 2009 Yrjö Jahnsson Award/news/news_2009/Reenen_Award.htm/news/news_2009/Reenen_Award.htmEC clears Lufthansa/Austrian Airlines merger, subject to conditions/news/news_2009/Lufthansa-AustrianAir.htm/news/news_2009/Lufthansa-AustrianAir.htmOFT clears Centrica acquisition of British Energy stake unconditionally/news/news_2009/Centrica.htm/news/news_2009/Centrica.htmEuropean Commission clears Pfizer/Wyeth merger at Phase I, subject to conditions/news/news_2009/Pfizer_Wyeth.htm/news/news_2009/Pfizer_Wyeth.htm